Background: Vitamin C deficiency is prevalent in adults with heart failure (HF). Little is known about the relationship of dietary vitamin C deficiency with health outcomes in adults with HF. Objective: The study's aim was to determine the relationships of vitamin C deficiency measured at baseline with health-related quality of life (HRQOL) and cardiac event-free survival in patients with HF measured 1 year later. Method: A total of 251 patients with HF completed a 4-day food diary. Dietary vitamin C deficiency was defined as daily intake less than the estimated average requirement from the Institute of Medicine of 75 mg/d for men and 60 mg/d for women. Health-related quality of life was assessed using the Minnesota Living with Heart Failure Questionnaire at 12 months. Patients were followed for a median of 1 year to determine time to the first event of cardiac-related hospitalization or death. Data were analyzed by hierarchical linear and Cox proportional hazards regressions. Results: One hundred patients (40%) had vitamin C deficiency. Dietary vitamin C deficiency was associated with poorer HRQOL at 12 months (" = 0.16, P = .02) after controlling for demographic and clinical variables. During the follow-up period, 59 patients (24%) had cardiac events. In Cox regression, vitamin C deficiency predicted shorter cardiac event-free survival after adjusting for the same covariates (hazards ratio, 1.95; 95% confidence interval, 1.08Y3.51). Conclusion: Vitamin C deficiency was associated with poorer HRQOL and shorter cardiac event-free survival in patients with HF. The findings suggest that encouraging patients with HF to consume a diet rich in fruits/vegetables to prevent vitamin C deficiency may lead to better health outcomes.
A lthough significant advancements in morbidity and mortality have resulted from improved medical treatment, heart failure (HF) remains a prevalent, morbid, and costly condition with a high early mortality rate.
1Y6 Currently, 6.5 million Americans have HF.
1Y3
Even after optimum medical treatment, up to 84% patients with HF remain symptomatic 7, 8 ; these symptoms are associated with decreased health-related quality of life (HRQOL), as well as frequent hospitalization. 9, 10 Approximately half of the patients with HF are readmitted within 6 months of hospital discharge for exacerbations of HF. 11, 12 Mean serum vitamin C levels are significantly lower in patients with HF compared with those with other chronic conditions, 13Y15 and up to 39% of patients are reported to have a dietary vitamin C deficiency.
14 Consequences of low serum vitamin C include increased oxidative stress and decreased physical performance. 16 In a large study of community-dwelling older people, low serum vitamin C concentrations were associated with all-cause and cardiac-related mortality. 17 Previous studies have shown that higher vitamin C levels are associated with better endothelial cell and immune system function and a lower risk for cardiovascular disease in healthy adults. 18Y21 In patients with HF, serum vitamin C levels are positively correlated with cardiac function (measured by left ventricular ejection fraction). 22 Furthermore, those with dietary vitamin C deficiency (ie, those who consumed G100 mg/d of vitamin C) had about 2 times the risk of experiencing a cardiac event in a recent prospective study of Korean patients with HF. 14 Little is known about the effects of dietary vitamin C deficiency on outcomes important to patients with HF. There are no studies of vitamin C deficiency and HRQOL, and the relationship between vitamin C intake and cardiac event-free survival has only been examined in 1 study of patients with HF in Korea.
14 Accordingly, the purpose of this study was to determine the relationship of dietary vitamin C deficiency with HRQOL and cardiac event-free survival in patients with HF. We hypothesized that patients with HF and dietary vitamin C deficiency would have poorer HRQOL and shorter cardiac event-free survival than patients with HF and no deficiency.
Methods

Study Design
This was a secondary data analysis of a longitudinal study in which patients' sociodemographic (eg, age, gender, race/ethnicity) and clinical (eg, comorbidities [diabetes, hypertension], left ventricular ejection fraction, New York Heart Association functional class, body mass index, medications) data were collected at baseline by patient interview and medical record review. Dietary vitamin C intake/deficiency, as well as total energy intake and vegetable and fruit food serving size, was determined from a 4-day food diary. Health-related quality of life was assessed by patient interview at 12 months by phone. Cardiac events were followed by patient/family interview and hospital medication record review.
Samples and Setting
Detailed eligibility criteria and recruitment methods have been published previously. 8 Patients were recruited from clinics associated with 3 large community hospitals or academic medical centers in 3 Midwestern states. Patients were included if they had a confirmed diagnosis of chronic HF. Patients were excluded if they had a terminal illness or an obvious cognitive impairment that precluded provision of informed consent.
Measures
Vitamin C Deficiency Dietary vitamin C intake was defined as the averaged 4-day intake from food diaries (3 weekdays and 1 weekend day), a method that is widely used to measure nutritional intake and dietary patterns. 23 The diets from the 4-day food diary were analyzed using Nutrition Data Systems for Research software (NCC, University of Minnesota). 24, 25 The Nutrition Data Systems for Research is a valid, widely used program to analyze dietary intake to determine nutrient deficiency in multiple patient populations. 24, 25 Dietary vitamin C deficiency was defined as daily intake less than the estimated average requirement of 75 mg/d for men and 60 mg/d for women from the Institute of Medicine. 26 Health-Related Quality of Life The Minnesota Living with Heart Failure questionnaire (MLHFQ) is a measure of HRQOL that assesses the patient's perceptions of the influence of HF on physical and emotional aspects of life. 27, 28 The 21 items are summed, with higher scores indicating worse HRQOL. Researchers have demonstrated evidence for validity (MLHFQ scores were associated with survival) and reliability (Cronbach !s ranging from .88 to .93), and the instrument has been widely used to measure HRQOL in patients with HF. 27Y29 In this study, the Cronbach ! was .95. The MLHFQ has physical (items 2Y7, 12, and 13) and emotional (items 17Y21) subscales to measure physical and emotional aspects of HRQOL. The Cronbach !s for the subscales in this study were .95 and .93, respectively.
Cardiac Event-free Survival
The outcome variable was the composite end point of time to the first cardiac event, whether it was a cardiacrelated hospitalization or death. Data on cardiac events were collected monthly by patient phone calls, hospital record review, and review of death certificates. We calculated number of days from baseline to the first cardiac event during the follow-up period.
Covariates
Age, gender, race/ethnicity, education, financial status, left ventricular ejection fraction, New York Heart Association functional class, body mass index, comorbidity (diabetes, hypertension), and medication use (angiotensin-converting enzyme inhibitor and "-blocker), which might influence health outcomes (HRQOL and cardiac event-free survival), were collected as covariates. 8, 30, 31 We also assessed patients' total energy intake and fruit and vegetable serving size using the 4-day food diary as these might influence dietary vitamin C intake and deficiency. 32 Patients' sociodemographic and clinical characteristics were collected from the medical record and patient interview. Patients' New York Heart Association functional class was determined by a structured patient interview at baseline. 33 On the basis of patients' reports of symptoms associated with performing their usual activities, they were assigned to classes I (ordinary activity causes no symptoms) to IV (symptoms occur at rest). 33 
Procedure
Permission to conduct the study was obtained from the institutional review board at all sites. A trained research nurse visited patients in their home to explain the study and obtain informed written consent. Patients were provided with digital scales and face-to-face instructions with return demonstrations on how to use digital scales to weigh each food item and record it in the food diary. Written instructions were also provided. The patient completed food diaries on 3 weekdays and 1 weekend day before baseline measurements according to the patient's schedule (usually Wednesday through Saturday). Patients did not record food diaries during any week that included a holiday or other special occasions. The research nurse contacted patients by phone on day 1 to remind them to start recording the food diary and to verify accuracy of recording the first meal. The 4-day food diary was reviewed by a registered dietitian to verify portions and food preparation and complete any missing data during the baseline visit to the clinical research center. Patients' sociodemographic and clinical data were collected by interview and medical record review at baseline. Health-related quality of life was assessed by patient interview at 12 months by phone. Patients were followed to collect data on cardiac events (cardiac hospitalization or death).
Data Management and Analysis
All data analyses were conducted using IBM SPSS version 24.0 (Armonk, New York); a significance level of .05 was determined a priori. Data analysis began with a descriptive examination of all variables, including frequency distributions, means, standard deviations, and medians, as appropriate to the level of measurement of the variables. Student independent t tests and # 2 tests were used to compare differences between dietary vitamin C adequacy and deficiency groups.
We used hierarchical linear regression to examine the relationship between dietary vitamin C deficiency and HRQOL (total scores, as well as scores for the physical and emotional subscales) with and without potential confounding covariates: age, gender, LVEF, New York Heart Association functional class, Angiotensin Converting Enzyme Inhibitor use, and "-blocker use, BMI, hypertension, diabetes, and total energy intake. The Kaplan-Meier with log-rank test was used to compare the time to cardiac event-free survival between patients with and without vitamin C deficiency. Hierarchical Cox proportional hazards regression modeling was used to assess the time to the first cardiac event between patients with and without vitamin C deficiency and with and without adjusting for the same covariates listed previously.
Results
Patient Characteristics
The sample included 251 patients with a mean age of 61 years and an average left ventricular ejection fraction of 34.4% (Tables 1 and 2 ). The most common HF etiology was ischemic heart disease. Most patients were male, white, and married. About half of the patients had New York Heart Association III/IV. More than one-quarter of patients (26%) reported not having enough income to make ends meet.
Dietary Vitamin C Deficiency
The median dietary vitamin C intake was 90 mg/d (T495 mg), which was higher than the recommended dietary vitamin C intake for both male (75 mg/d) and female (60 mg/d) adults. The range of dietary vitamin C intake was from 1.1 to 6199 mg/d. One hundred fifty-one patients (60%) consumed recommended amounts of dietary vitamin C, whereas 100 patients (40%) had dietary vitamin C deficiency. There were no gender and race/ethnicity differences in dietary vitamin C deficiency.
Dietary Vitamin C Deficiency and Health-Related Quality of Life
The mean score for the MLHFQ at 12 months was 42.3 (T24.5). The mean scores of the physical and emotional aspects of the MLHFQ at 12 months were j3.699, P G .001), indicating more physical symptoms in patients with dietary vitamin C deficiency. There was no difference between groups in the emotional subscale of the MLHFQ (t = j1.267, P = .21). The hierarchical multiple linear regression model for the prediction of total MLHFQ scores is shown in Table 3 . Dietary vitamin C deficiency and higher (worse) NYHA functional class were associated with higher total MLHFQ (ie, poorer HRQOL; F = 4.749, P G .001). Similarly, dietary vitamin C deficiency and NYHA functional class predicted worse physical aspect of the MLHFQ (F = 5.175, P G .001). Dietary vitamin C deficiency did not predict the emotional aspect of the MLHFQ (P = .69).
Dietary Vitamin C Deficiency and Cardiac Event-free Survival
There were 59 cardiac events (3 cardiac deaths and 56 cardiac hospitalizations) during the follow-up period, with 31 events in patients with dietary vitamin C deficiency and 28 events in those who had adequate dietary vitamin C intake. Kaplan-Meier plots and log-rank tests demonstrated that cardiac event-free survival was significantly worse in patients who had dietary vitamin C deficiency (P = .017; Figure) . In unadjusted Cox proportional hazards regression, patients with dietary vitamin C deficiency had shorter cardiac event-free survival compared with those with dietary vitamin C adequacy (hazards ratio, 1.85; 95% confidence interval, 1.11Y3.09; P = .019). When adjusting for age, gender, left ventricular ejection fraction, New York Heart Association functional class, Angiotensin Converting Enzyme Inhibitor use, "-blocker use, body mass index, hypertension, diabetes, and total energy intake, dietary vitamin C deficiency remained a significant predictor of cardiac event-free survival (hazards ratio, 1.95; 95% confidence interval, 1.08Y3.51; P = .026; Table 4 ). In the adjusted model with all covariates, none of the covariates was associated with cardiac event-free survival. In each adjusted regression model, all variance inflation factors were less than 1.2, suggesting no parameter distortion due to multicollinearity.
Discussion
This is the first study in patients with HF examining the relationship between dietary vitamin C and HRQOL. The findings of this study supported our hypothesis that patients with dietary vitamin C deficiency will have worse HRQOL compared with those with adequate dietary vitamin C intake. In this study, the mean score for the MLHFQ at 12 months was 42.3, which was already much higher than the MLHFQ score of 14 among the healthy older adults, 34 indicating poorer HRQOL in patients with HF than healthy older adults. Patients with dietary vitamin C deficiency had higher total MLHFQ scores than those with adequate dietary vitamin C intake (49.3 vs 37.9). Our result is in line with previous intervention studies that demonstrated that vitamin C supplementation improved physical activity level, 35 HRQOL, and symptoms of fatigue, insomnia, poor appetite, nausea, and pain in patients with cancer.
36Y38
Our results also showed that dietary vitamin C deficiency was associated with shorter cardiac eventfree survival compared with vitamin C adequacy. The finding is consistent with a similar prospective study in Korean patients with HF.
14 Although the research on the effect of vitamin C to reduce cardiac events is mixed, a large body of evidence shows beneficial effects of vitamin C on health outcomes, such as reducing cold incidence in healthy adults, 35 alleviating a number of cancer-and chemotherapy-related symptoms (eg, fatigue, loss of appetite) in patients with cancer, enhancing the immune system, and improving recovery from infectious diseases and respiratory infections.
36Y40 Patients with HF are more likely to have dietary vitamin C deficiency compared with those with other chronic illnesses.
13Y15 Because vitamin C is not synthesized, not stored in the body, and readily excreted in the urine, it must be continuously replaced in the diet and supplements if necessary. In this study, 40% of the patients with HF had dietary vitamin C deficiency. Our findings on the high prevalence of vitamin C deficiency is consistent with the current literature. 41 Considering the importance of dietary vitamin C intake in terms of HRQOL and cardiac event-free survival for patients with HF from observational studies (previous and our studies), 14 future randomized controlled trials are needed to test whether providing more vitamin C supplementation to those patients with HF and vitamin C deficiencies improves patients' HRQOL and impacts cardiac event-free survival.
The mechanism underlying the relationship between dietary vitamin C deficiency, poorer HRQOL, and worse cardiac event-free survival is not known. One possible explanation for this relationship in HF may be that lower vitamin C leads to endothelial dysfunction, which increases systemic vascular resistance and afterload, leading to low cardiac output 42 and subsequent HF symptoms (eg, edema, shortness of air, and fatigue). 42, 43 Heart failure symptoms produced by low cardiac output insufficient to support patients' activities of daily living are potential reasons for decreased HRQOL 9,10 and hospitalizations. 44 Previous studies have demonstrated that higher vitamin C levels were associated with improved endothelial function.
18Y20
There was a significant positive correlation between cardiac function and serum vitamin C level. 22 In intervention studies in patients with HF, investigators found that vitamin C supplementation increased serum vitamin C levels 20 and improved endothelial function. 19, 20, 45 Other interventional studies provided evidence that vitamin C supplementation not only improved cardiac function 18, 46, 47 but also reduced oxidative stress 20, 48 in patients with HF. Therefore, patients with dietary vitamin C deficiency may be more likely to have endothelial dysfunction, low cardiac output, more HF symptoms, poorer HRQOL, and worse cardiac event-free survival. Consistent with this hypothesis, our study showed that the physical aspect of HRQOL was significantly worse in patients with dietary vitamin C deficiency, providing evidence that patients with dietary vitamin C deficiency had more symptoms of HF (such as shortness of breath, fatigue, and less physical strength to move around) that impair patients' HRQOL. Additional research is needed to confirm this potential mechanism. Our study has several limitations. First, dietary vitamin C intake was measured at 1 time point that might not reflect habitual dietary vitamin C intake. Longitudinal and repeated measurements of dietary vitamin C intake are needed to confirm our findings. Second, dietary vitamin C intake was not confirmed using serum vitamin C concentration. Third, our sample was relatively small, mostly white, male, and married. Therefore, our findings warrant further study to confirm these results in a more diverse sample of patients with HF.
In conclusion, vitamin C deficiency was associated with poor HRQOL and shorter event-free survival. The findings suggest that patients with HF should be encouraged to consume a diet rich in fruits and vegetables to prevent dietary vitamin C deficiency, while awaiting confirmation from future randomized controlled trials to confirm that vitamin C supplementation actually results in better health outcomes for patients with HF.
What's New and Important
h Two-fifths of the patients with HF had vitamin C deficiency. h Patients with dietary vitamin C deficiency measured at baseline had poorer HRQOL at 12 months than those with adequate dietary vitamin C intake. h Dietary vitamin C deficiency was associated with shorter event-free survival. h Encouraging patients with HF to consume a diet rich in fruits/vegetables to prevent vitamin C deficiency may lead to better health outcomes.
